✦ LIBER ✦

A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells

✍ Scribed by Courtney R. Giordano; Kelly L. Mueller; Laura J. Terlecky; Kendra A. Krentz; Aliccia Bollig-Fischer; Stanley R. Terlecky; Julie L. Boerner

Book ID: 116981119
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 820 KB
Volume: 318
Category: Article
ISSN: 0014-4827
DOI: 10.1016/j.yexcr.2012.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug Resistance in Cancer Cells || Mecha

Drug Resistance in Cancer Cells || Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors

✍ Siddik, Zahid H.; Mehta, Kapil 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 663 KB

It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can

Activation of alternative HER receptors

Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells

✍ A. Kong; V. Calleja; P. Leboucher; A. Harris; P. Parker; B. Larijani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Targeting the receptor tyrosine kinase R

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance

✍ Plaza-Menacho, I; Morandi, A; Robertson, D; Pancholi, S; Drury, S; Dowsett, M; M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 943 KB

485 POSTER Activation of alternative HER

485 POSTER Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells

✍ A. Kong; V. Calleja; P. Leboucher; A. Harris; P. Parker; B. Larijani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

AZD3409 inhibits the growth of breast ca

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

✍ Monica R. Maiello; Amelia D’Alessio; Antonella De Luca; Adele Carotenuto; Anna M 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 290 KB

Breast cancer cells with acquired resist

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling

✍ Nicola Normanno; Manuela Campiglio; Monica R. Maiello; Antonella De Luca; Mario 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 408 KB